Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1Shenghao Li, Xinli Shi, Jingmin Ji et al.|Molecular and Cellular Biochemistry|2020Cited by 51
Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting <scp>YAP1</scp> expression to enhance <scp>anti‐PD</scp>‐1 efficacyQing Peng, Yiwei Liu, Yinglin Guo et al.|Phytotherapy Research|2022Cited by 33
Human umbilical cord mesenchymal stem cells promoted tumor cell growth associated with increased interleukin-18 in hepatocellular carcinomaYanguang Yang, Xinli Shi, Shenghao Li et al.|Molecular Biology Reports|2024Cited by 3
Cisplatin Increased the Expression of PD-1 and PD-L1 by YAP1 in Hepatocellular CarcinomaLiyuan Hao, Xinli Shi, Yinglin Guo et al.|Research Square|2021Cited by 0
Dihydroartemisinin broke immune evasion through YAP1/JAK1/STAT1, 3 pathways to enhance anti-PD-1 therapy in hepatocellular carcinomaQing Peng, Yi-Wei Liu, Shenghao Li et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0